Mody et al. reported a complete remission by the fourth cycle of therapy in a case of metastatic, wild-type EGFR, gallbladder cancer infiltrating liver with lymph node metastasis treated with gemcitabine and erlotinib, and the treatment was continued for 12 cycles. The gene discussed is EGFR; the disease is gallbladder cancer.